Summary
Psoriasis is a disease of abnormal proliferation and differentiation of epidermal cells. Several cytokines released by keratinocytes are implicated as factors responsible for this pathological condition of the epidermis. In order to elucidate the role of these cytokines in psoriasis, messenger RNA (mRNA) expression of interleukin-1 (IL-1) and IL-6 in psoriatic epidermis was investigated using biotin-labelled complementary DNA (cDNA) of the cytokines. Messenger RNA of IL-1α was weakly detected in some normal healthy epidermis specimens and more strongly in all the perilesional uninvolved psoriatic epidermis specimens. It was also expressed in the transitional zone between uninvolved and fully developed psoriatic skin, but was not expressed in lesional skin. In contrast, IL-6 mRNA was rarely expressed in normal healthy epidermis, but was expressed in perilesional uninvolved psoriatic epidermis, in the transitional zone and in the fully developed lesional epidermis, with the maximum intensity in the transitional zone. Expression of mRNA of IL-6 receptor showed a similar tendency to that of IL-6. It was expressed in psoriatic epidermis, most strongly in the transitional zone, but not in normal healthy epidermis. IL-6 was demonstrated immunohistochemically in psoriatic epidermis, but IL-6 receptor was demonstrated only in the transitional zone. Thus IL-6 and its receptor expression correlated well with the formation of psoriatic lesions where IL-1 may initiate their expression. IL-6 may play an important role in the pathogenesis of psoriasis.
Similar content being viewed by others
References
Blanton RA, Kupper TS, McDougall JK, Dower S (1989) Regulation of interleukin-1 and its receptor in human keratinocytes. Proc Natl Acad Sci USA 86:1273–1277
Camp R, Fincham N, Ross J, Bird C, Gearing A (1990) Potent inflammatory properties in human skin of interleukin-1 alpha-like material isolated from normal skin. J Invest Dermatol 94:735–741
Chodakewitz JA, Kupper TS, Coleman DL (1988) Keratinocyte-derived granulocyte/macrophage colony-stimulating factor induces DNA synthesis by peritoneal macrophages. J Immunol 140:832–836
Cooper KD, Hammerberg C, Baadsgaard O, Elder JT, Chan LS, Sauder DN, Voorhees JJ, Fisher G (1991) IL-1 activity is reduced in psoriatic skin. Decreased IL-1 α and increased nonfunctional IL-1 Β. J Immunol 144:4598–4603
Elder JT, Fisher GJ, Lindquist PB, Bennett GL, Pittelkow MR, Coffey RJ Jr, Ellingsworth L, Derynck R, Voorhees JJ (1989) Overexpression of transforming growth factor alpha in psoriatic epidermis. Science 243:811–814
Fincham NJ, Camp RDR, Gearing AJH, Bird CR, Cunningham FA (1988) Neutrophil chemoattractant and IL-1-like activity in samples from psoriatic skin lesions. Further characterization. J Immunol 140:4294–4299
Furutani Y, Notake H, Yamayoshi N, Yamaguchi J, Nomura H, Ohue M, Furuta T, Yamada M, Nakamura S (1985) Cloning and characterization of the cDNA from human and rabbit interleukin-1 precursor. Nucleic Acids Res 13:5869–5882
Gahring LC, Buckley A, Daynes RA (1985) Presence of epidermal-derived thymocyte activating factor/interleukin 1 in normal human stratum corneum. J Clin Invest 76:1585–1591
Grossman RM, Krueger J, Yourish D, Granelli-Piperno A, Murphy DP, May L, Kupper TS, Sehgal PB, Gottlieb AB (1989) Interleukin-6 is expressed in high levels in psoriatic skin and stimulates proliferation of cultured human keratinocytes. Proc Natl Acad Sci USA 86:6367–6371
Hauser C, Saurat JH, Schmitt A, Jaunin F, Dayer JM (1986) Interleukin-1 is present in normal human skin. J Immunol 136:3317–3323
Hirano T, Yasukawa K, Harada H, Taga T, Watanabe Y, Matsuda T, Kashiwamura S, Nakajima K, Iwamatsu A, Tsunasawa S, Sakiyama F, Matsui H, Takahara Y, Taniguchi T, Kishimoto T (1986) Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin. Nature 324:73–78
Hirata Y, Taga T, Hibi M, Nakano N, Hirano T, Kishimoto T (1989) Characterization of IL-6 receptor expression by monoclonal and polyclonal antibodies. J Immunol 143:2900–2906
Kirnbauer R, Koeck A, Schwarz T, Urbanski A, Krutmann J, Borth W, Damm D, Shipley G, Ann JC, Luger TA (1989) IFN-2, B cell differentiation factor 2, or hybridoma growth factor (IL-6) is expressed and released by human epidermal cells and epidermoid carcinoma cell lines. J Immunol 142:1922–1928
Kishimoto T (1989) The biology of interleukin-6. Blood 74:1–10
Kupper TS (1989) Mechanism of cutaneous inflammation. Arch Dermatol 125:1406–1412
Kupper TS, Ballard DW, Chua AO, McGuire JS, Flood PM, Horowitz MC, Langdon R, Lichtfoot L, Gubler U (1989) Human keratinocytes contain mRNA indistinguishable from monocyte interleukin-1 and mRNA. J Exp Med 164:2095–2100
Luger TA, Stadler BM, Katz SI, Oppenheim JJ (1985) Epidermal cell (keratinocyte) derived thymocyte activating factor (ETAF). J Immunol 127:1493–1498
Luger TA, Schwarz T, Krutmann J, Kirnbauer R, Neuner P, Koeck A, Urbanski A, Borth W, Schauer E (1989) Interleukin-6 is produced by epidermal cells and plays an important role in the activation of human T-lymphocytes and natural killer cells. Ann NY Acad Sci 557:405–414
Maniatis T, Fritsch EF, Sambrook J (1982) Molecular cloning. A laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, New York
Matsuda T, Hirano T, Kishimato T (1988) Establishment of an interleukin 6 (IL6)/B cell stimulatory factor 2 (BSF-2)-dependent cell line and preparation of anti-IL6/BSF-2 monoclonal antibodies. Eur J Immunol 18:951–956
Navarro S, Debili N, Bernaudin J-F, Vainchenker W, Doly J (1989) Regulation of the expression of IL-6 in human monocytes. J Immunol 142:4339–4345
Nishioka K, Funato T, Sato Y, Ohta H, Eto H, Katayama I, Nishiyama S (1990) Production of interleukin-1 alpha by a trichilemmoma cell line. J Dermatol 17:205–210
Ristow HJ (1987) A major factor contributing to epidermal proliferation in inflammatory skin diseases appears to be interleukin-1 or a related protein. Proc Natl Acad Sci USA 84:1940–1944
Romero LI, Ikejima T, Pincus SH (1989) In situ localization of interleukin-1 in normal and psoriatic skin. J Invest Dermatol 93:518–522
Takematsu H, Suzuki R, Tagami H, Kumagai K (1986) Interleukin-1-like activity in horny layer extracts: decreased activity in scale extracts of psoriasis and sterile pustular dermatoses. Dermatologica 172:236–240
Yamasaki K, Taga T, Hirata Y, Yawata H, Kawanishi Y, Seed B, Taniguchi T, Hirano T, Kishimoto T (1989) Cloning and expression of the human interleukin-6 (BSF2/IFN 2) receptor. Science 241:825–828
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ohta, Y., Katayama, I., Funato, T. et al. In situ expression of messenger RNA of interleukin-1 and interleukin-6 in psoriasis: interleukin-6 involved in formation of psoriatic lesions. Arch Dermatol Res 283, 351–356 (1991). https://doi.org/10.1007/BF00371814
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00371814